# Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)

> **NCT00418743** · — · UNKNOWN · sponsor: **Groupe Francais De Pneumo-Cancerologie** · enrollment: 138 (estimated)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00418743
- **Lead sponsor:** Groupe Francais De Pneumo-Cancerologie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2010-05
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2010-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418743, "Second-line Treatment in Patients With Small Cell Lung Cancer (SCLC)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00418743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*